Kura Oncology, Inc.
KURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $224 | $37 | $52 | $91 |
| Short-Term Investments | $503 | $387 | $386 | $427 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $17 | $9 | $8 | $4 |
| Total Curr. Assets | $745 | $432 | $446 | $522 |
| Property Plant & Equip (Net) | $7 | $9 | $6 | $8 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $8 | $8 | $3 | $4 |
| Total NC Assets | $15 | $16 | $10 | $12 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $760 | $449 | $456 | $534 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $2 | $3 |
| Short-Term Debt | $4 | $2 | $2 | $2 |
| Tax Payable | $2 | $0 | $0 | $0 |
| Deferred Revenue | $24 | $0 | $0 | $0 |
| Other Curr. Liab. | $46 | $31 | $20 | $17 |
| Total Curr. Liab. | $79 | $35 | $24 | $22 |
| LT Debt | $12 | $16 | $12 | $5 |
| Deferred Rev, NC | $254 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2 | $1 | $0 | $0 |
| Total NC Liab. | $268 | $16 | $12 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $7 | $8 | $5 | $7 |
| Total Liabilities | $347 | $52 | $36 | $27 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$895 | -$721 | -$569 | -$433 |
| AOCI | $1 | -$1 | -$8 | -$2 |
| Other Equity | $1,308 | $1,120 | $997 | $941 |
| Total Equity | $414 | $397 | $420 | $507 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $760 | $449 | $456 | $534 |
| Net Debt | -$208 | -$20 | -$38 | -$84 |